-
1 month ago | 
thefifthestate.com.au | Samantha Marshall
There was no shortage of questions from the audience at our first leaders forum on 4 March with speakers Matt Kean, chair of the Climate Change Authority and Martijn Wilder, founder of Pollination. They came thick and fast, managed by the indefatigable Rachel Alembakis of U Ethical.
-
Oct 8, 2024 | 
lexology.com | Alice Valder Curran |Ken Choe |Melissa Bianchi |Joy Sturm |Allison Pugsley |Kathleen Peterson | +6 more
On October 2, 2024, the Centers for Medicare & Medicaid Services (CMS) issued final guidance for initial price applicability year (IPAY) 2027 of the Drug Price Negotiation Program established by the Inflation Reduction Act (IRA) (“Final Guidance”). The Final Guidance largely represents a continuation of CMS’s IPAY 2026 approach.
-
Sep 23, 2024 | 
lexology.com | Alice Valder Curran |Ken Choe |Kathleen Peterson |Samantha Marshall |Mahmud Brifkani |Rianna Modi | +4 more
On September 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule entitled: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program.
-
Jul 29, 2024 | 
lexology.com | Alice Valder Curran |Ken Choe |Stuart Langbein |Kathleen Peterson |Samantha Marshall |Mahmud Brifkani | +2 more
The Centers for Medicare & Medicaid Services (CMS) recently issued several important updates concerning the reporting of Average Sales Price (ASP) with potential implications for manufacturers.
-
Jul 8, 2024 | 
tkmagazine.com | Samantha Marshall
By SAMANTHA MARSHALL Photos by JENNIFER GOETZ On the cusp of expansion, the partners at Topeka Auto Glass share the principles behind their company’s rapid growth. The three co-partners behind Topeka Auto Glass aren’t shy to admit they believe they’re the best in the business. After working for other shops for a collective 30-plus years, they were clear about the business practices they didn’t agree with.
-
May 6, 2024 | 
lexology.com | Alice Valder Curran |Ken Choe |Susan Cook |Kathleen Peterson |Samantha Marshall |Lindsey Johnson | +3 more
On May 3, 2023, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for initial price applicability year (IPAY) 2027 of the Drug Price Negotiation Program established by the IRA. Notwithstanding the agency’s oft-stated claim in litigation that its guidance for IPAY 2027 may differ from that for IPAY 2026, the draft guidance largely represents a continuation of CMS’s IPAY 2026 approach.
-
Apr 3, 2024 | 
lexology.com | Ken Choe |Alice Valder Curran |Melissa Bianchi |James Huang |Samantha Marshall |Mahmud Brifkani | +1 more
On April 2, 2024, the Centers for Medicare & Medicaid Services (CMS) released the 2025 Notice of Benefit and Payment Parameters (NBPP) final rule (Final Rule), finalizing policies applicable to qualified health plans offered on health insurance exchanges as well as certain policies applicable to certain health plans more broadly.
-
Dec 18, 2023 | 
lexology.com | Alice Valder Curran |Ken Choe |Kathleen Peterson |James Huang |Samantha Marshall |Mahmud Brifkani | +3 more
On December 14, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “revised” guidance documents implementing the Medicare Part B and Part D inflation rebate provisions of the Inflation Reduction Act of 2022 (IRA). Although the overall structure of the implementation of the Part B and Part D inflation rebates remains the same, CMS did change some aspects of the programs in response to comments and intends to further revisit implementation through future rulemaking.
-
Nov 26, 2023 | 
smartindustry.com | Samantha Marshall
The nation’s small and midsize industrial manufacturers—who continually face material sourcing bottlenecks, workforce shortages, and inflationary pressures—increasingly turn to technology and automation to ease the burden. Technology is part of the solution, certainly. However, manufacturers often select and implement technology systems on an ad-hoc basis without surveying potential wider use across their organizations.
-
Nov 7, 2023 | 
lexology.com | Alice Valder Curran |Ken Choe |Cate Stetson |Susan Cook |Kathleen Peterson |Kathleen McGrath | +4 more
On November 3, 2023, the U.S. District Court for the District of South Carolina issued a decision granting in large part Genesis Health Care’s (Genesis’s) motion for summary judgment in its litigation against the Health Resources and Services Administration (HRSA) over the 340B “patient” definition.
